Most at risk: the millions of Americans who are still unvaccinated or not fully vaccinated, and those whose immune systems are compromised or have been suppressed and do not respond to vaccinations. These include patients being treated for cancer or who have received organ transplants.
That is why antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered by James Crowe Jr., MD, Robert Carnahan, PhD, and colleagues at Vanderbilt University Medical Center, are so important in the continuing fight against COVID-19.